#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Noam Diamant Email
Head Business Development . Senseera
Jerusalem,
Locationn***********@senseerahealth.com
Primary EmailHow to contact Noam Diamant
Join and see Noam's contact info for free!Current Roles
Employees:
19Revenue:
$0About
Senseera's GEM (Genomic Expression Maps) BIOMARKERS, is a novel biomarker discovery platform based on a patent protected chromatin epigenomics (cfChIP-seq) liquid biopsy technology (Sadeh, Nature Biotechnology, 2021). \n\nGEM BIOMARKERS turns a simple blood draw into unparalleled, quantitative, cell-specific gene expression, and regulation data from cell-free DNA. Going beyond traditional methods like cfDNA genomics and methylation, it offers a transformative layer of data for various applications including biomarker discovery, tissue-agnostic MRD detection, response to therapy, dose optimization, disease subtyping and more.\n\nBacked by a database of over 20,000 annotated disease samples and a 2,000+ healthy subjects cohort, Senseera is collaborating with leading drug developers from big pharma and biotechs, to deliver mechanistic insights with exceptional sensitivity and specificity across multiple indications, advancing human health and precision medicine worldwide.Senseera Address
Jerusalem, null
il